Class Action

Maximum Strength Robitussin Cough+Chest Congestion DM

Class Action

Maximum Strength Robitussin Cough+Chest Congestion DM

In September 2017, a class-action lawsuit was filed against Pfizer for allegedly misleadingly marketing Maximum Strength Robitussin Cough+Chest Congestion DM to make consumers believe that the maximum strength product contains more of the active ingredients than the regular strength product when, according to the plaintiffs, the two products contain the same amount of one of the active ingredients (expectorant) and the regular strength products contains more of the other active ingredient (cough suppressant). (Haj et al v. Pfizer Inc., Case No. 17-cv-6730, N.D. Ill.)

For more information about other class-action lawsuits regarding cough medicines and TINA.org’s coverage of the products, click here.


Class-Action Tracker

ChapStick Natural Claims

Class Action

ChapStick Natural Claims

In December 2020, a class-action lawsuit was filed against GlaxoSmithKline Consumer Healthcare Holdings and Pfizer for allegedly falsely advertising ChapStick products as natural when, according to plaintiffs, the products contain…

Total Hydration ChapStick

Class Action

Total Hydration ChapStick

December 2018: This case was voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed. September 2016: A class-action…

The Packaging of Advil®

Class Action

The Packaging of Advil®

In October 2016, a federal court dismissed a false advertising class-action lawsuit filed against Pfizer in 2015. The complaint had alleged that the company misleadingly uses You know when you…

Centrum Multi-Vitamins

Class Action

Centrum Multi-Vitamins

March 2016: A federal judge denied plaintiff’s request for permission to file a second amended complaint finding that the amended complaint would not survive a motion to dismiss and, as…


The Latest

Filters


Show More